title: [Ventricular fibrillation as a symptom of prosthetic valve dysfunction that was caused by thrombosis on mitral valve. Surgery or thrombolytic treatment?].
abstract: We discuss the case of 49 years old woman with recurrent thrombosis of prosthetic mitral valve with ventricular fibrillation as the complication. For the first time thrombotic prosthetic valve Carbo Medics 33 had been removed and the new valve--Medtronic Hall 31 mm was implanted in the mitral position. After diagnosis of the repeated thrombosis on the replaced prosthetic valve, the patient refused the subsequent operation. The fully effective thrombolytic therapy was then performed. The patient was discharged from the Department and was asymptomatic 4 month follow-up.
authors.affiliation: I Klinika Wad Serca Instytutu Kardiologii w Warszawie.
authors.forename: A
authors.initials: A
authors.lastname: Brzezińska
authors.forename: A
authors.initials: A
authors.lastname: Bieganowski
authors.forename: J
authors.initials: J
authors.lastname: Heybowicz
authors.forename: E
authors.initials: E
authors.lastname: Orłowska-Baranowska
authors.forename: I
authors.initials: I
authors.lastname: Rawczyńska-Englert
mesh_terms: D003328:Coronary Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D011475:Prosthesis Failure; D012008:Recurrence; D015912:Thrombolytic Therapy; D014693:Ventricular Fibrillation / Q000209:etiology*
chemical_list: D005343:Fibrinolytic Agents